Document is current
Any future updates will be listed below
-
Authors
Peabody, John W.
Paculdo, David
de Belen, Enrico
Ganesan, Divya
Cooney, Isabella
Trujillo, Nelson
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05237271 at ClinicalTrials.govDocuments that mention this clinical trial
Clinical utility of a novel test for assessing cardiovascular disease risk in type 2 diabetes: a randomized controlled trial
https://doi.org/10.1186/s13098-023-01122-w
- License Information
-
More Information
Article History
Received: 16 March 2023
Accepted: 23 June 2023
First Online: 13 July 2023
Declarations
:
: The study was conducted in accordance with ethical standards, approved by Advarra Institutional Review Board, Columbia, MD, and registered on clinicaltrials.gov (NCT05237271). Informed consent was obtained from all participants through an online voluntary consent process. All data were kept confidential.
: Not applicable.
: CPVs®, QURE Healthcare’s proprietary simulated case tool, were used to collect data and score the responses. JWP, DP, EDB, DG, IC are employees of QURE Healthcare. NT is an employee of SomaLogic Operating Co., which funded the study. Otherwise, there are no disclosures.
